'Unfair and excessive pricing in Europe: pharma focus' for ICLG 2020
The 12th edition of the International Comparative Legal Guides ‘Competition Litigation 2020’, offers practical cross-border insight into competition litigation work, across 30 jurisdictions.
Two Hausfeld competition experts, Partner Anna Morfey and Counsel Luke Streatfeild authored one of the four ‘Expert Analysis Chapters’. Titled ‘Unfair and Excessive Pricing in Europe – Pharma Focus’, the piece explores the evolution of the law of unfair and excessive pricing, particularly its application in the pharmaceutical sector, and highlights how two prominent pharmaceutical cases are likely to provide guidelines for the future of regulation of this category of abuse.
The content covers common issues in competition litigation law and regulations – including interim remedies, final remedies, evidence, justification/defences, timing, settlement, costs, appeal, leniency and anticipated reforms.